Psilocybin: all 235 studies that test it
Page 3 of 3. Open to participants first (116), then studies with results posted, then the rest; newest registration first within each.
- Psilocybin Therapy for Depression in Bipolar II DisorderActive, not recruitingNCT05065294Phase 2
- Psilocybin for Treatment-Resistant DepressionCompletedNCT05029466Phase 2
- Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderActive, not recruitingNCT04982796Phase 1/2
- Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)TerminatedNCT04905121Phase 1
- Pilot RECAP Study in Healthy VolunteersCompletedNCT04842045Phase 1
- PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)Active, not recruitingNCT04754061Phase 1/2
- Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyActive, not recruitingNCT04718792Phase 2
- Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyCompletedNCT04661514Phase 2
- The Effect of Psilocybin on MDD Symptom Severity and Synaptic DensityCompletedNCT04630964Phase 2
- Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use DisorderActive, not recruitingNCT04620759Phase 2
- The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive DisorderStatus unknownNCT04593563Phase 2
- Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerCompletedNCT04522804Early Phase 1
- Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyCompletedNCT04505189Phase 1/2
- Precision Functional Brain Mapping in PsilocybinCompletedNCT04501653Early Phase 1
- An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)Active, not recruitingNCT04433858Phase 2
- The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.Status unknownNCT04433845Phase 2
- Prophylactic Effects of Psilocybin on Chronic Cluster HeadacheTerminatedNCT04280055Phase 1/2
- Repeat Dosing of Psilocybin in Migraine HeadacheCompletedNCT04218539Phase 1
- Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted PatientsCompletedNCT04141501Phase 2
- Effects of Psilocybin in Anorexia NervosaCompletedNCT04052568Phase 1
- Effects of Psilocybin in Concussion HeadacheTerminatedNCT03806985Phase 1
- Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the SelfCompletedNCT03736980Not applicable
- Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of ConceptCompletedNCT03715127Phase 2
- Direct Comparison of Altered States of Consciousness Induced by LSD and PsilocybinCompletedNCT03604744Early Phase 1
- Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive DisorderActive, not recruitingNCT03554174Phase 1
- Psilocybin and DepressionStatus unknownNCT03380442Phase 2
- Psilocybin for the Treatment of Migraine HeadacheCompletedNCT03341689Phase 1
- Psilocybin for Treatment of Obsessive Compulsive DisorderCompletedNCT03300947Phase 1
- The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious ProfessionalsCompletedNCT02421263Phase 1
- Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionCompletedNCT02243813Phase 1
- UW Psilocybin Pharmacokinetics StudyCompletedNCT02163707Phase 1
- Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsCompletedNCT01988311Phase 1
- Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV MelanomaWithdrawnNCT00979693Phase 2
- Psilocybin and Spiritual PracticeCompletedNCT00802282Phase 1
- Effects of Psilocybin in Advanced-Stage Cancer Patients With AnxietyCompletedNCT00302744Phase 1/2